The development of the production technology of 177Lutetium trichloride-Reference-Cited by-同舟云学术

The development of the production technology of 177Lutetium trichloride

Published:2018-08-07 Issue:3 Volume:18 Page:709-713
ISSN:1472-7978
Container-title:Journal of Computational Methods in Sciences and Engineering
language:
Short-container-title:JCM

Author:

Novikov S.G.¹,Berintsev A.V.¹,Alekseyev A.S.¹,Svetukhin V.V.¹,Kuznetsov R.A.¹,Zhukov A.V.¹,Fomin A.N.¹,Kovalnogov V.N.¹,Gorodetsky V.G.²,Karbolin P.V.²,Predeina M.A.²,Ivshin S.A.²,Ilyin K.I.²,Markov D.V.²

Affiliation:

1. S.P. Kapitsa Research Institute of Technology of Ulyanovsk State University, Ulyanovsk, Russia

2. JSC “Institute of Reactor Materials”, Zarechny, Russia

Publisher

IOS Press

Subject

Computational Mathematics,Computer Science Applications,General Engineering

Reference10 articles.

1. M. de Jong, S.M. Verwijnen, M. de Visser et al., Peptides for Radionuclide Therapy, in: Targeted Radionuclide Tumor Therapy: Biological Aspects, T. Stigbrand, J. Carlsson, G.P. Adams, eds. Dordrecht: Springer Netherlands, 2008, pp. 117–144. doi: 10.1007/978-l-4020-8696-0_7.

2. On the preparation of a therapeutic dose of 177Lu-labeled dota-tate using indigenously produced 177Lu in a medium flux reactor;Das;Applied Radiation and Isotopes,2007

3. Production of 177Lu at the new research reactor FRM-II: Irradiation yield of 176Lu177Lu;Dvorakova;Applied Radiation and Isotopes,2008

4. Y.G. Toporov, V.A. Tarasov, O.I. Andreev et al., Production of the 177Lu preparation of high specific activity in the SM research reactor, in: Proceedings of the 5th International Conference on Isotopes (5ici), 25–29 April 2005, Brussels, Belgium, C. Chemaly, B.J. Allen, H. Bonet, eds. Brussels, Belgium, 2005.

5. Production of 177Lu for targeted radionuclide therapy: Available options;Dash;Nuclear Medicine and Molecular Imaging,2015